A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT06815380 · RECRUITING
Trial details
- NCT number
- NCT06815380
- Sponsor
- Almirall, S.A.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-23
- Primary completion
- 2029-03-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.